Where the 28 days number comes from (it is not peptide data)
The 28-day figure often attached to peptides is a pharmacy standard for preserved multi-entry containers, tied to a 28-day microbiology test. It measures preservative performance, not what happens to a peptide in solution.
The 28-day figure comes from pharmacy practice standards, not from any measurement of peptides. USP General Chapter <797>, the US standard for sterile compounding, sets 28 days as the longest beyond-use date for an opened, preserved multi-entry compounded preparation, and it ties that number to USP <51>, a preservative-effectiveness test whose challenge runs for exactly 28 days. The figure describes how long an antimicrobial preservative is trusted to keep microbes from growing in a repeatedly opened container. It says nothing about how long any particular peptide survives in solution, which is a question of sequence and chemistry.
The origin: a pharmacy rule for preserved multi-entry preparations
CDC's guidance for healthcare providers repeats the USP <797> limit. The revised <797>, official since November 1, 2023 and current as of September 21, 2026, keeps the number and states where it comes from: USP's 2022 revision ties the 28-day limit for preserved multi-entry compounded preparations to passing the <51> preservative test.
Three things in that rule matter. It applies to preserved aqueous compounded preparations. It is a ceiling set by pharmacy practice, not a measurement of any ingredient. And it is conditional on passing <51>.
Why 28 days and not 30
USP <51>, Antimicrobial Effectiveness Testing, is the test a preservative system has to pass. Preservatives are added to multi-entry containers to limit microbial growth introduced by repeated entry.
The test inoculates the product with five organisms (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans and Aspergillus niger) and counts survivors at 7, 14 and 28 days. For the strictest category the bacteria must fall by at least 1 log at day 7, at least 3 logs at day 14, and show no increase from day 14 to day 28, while yeasts and molds must show no increase at any of the three points.
The 28 days is the length of the microbiology challenge. A preservative that passes has been shown to hold contamination down for 28 days of incubation. That is the evidence behind the beyond-use date, and it is the whole of the evidence. Nothing in the test measures the chemical integrity of the active ingredient, and nothing in it involves a peptide.
Why it is not a peptide stability figure
| The 28-day rule | Peptide stability in solution | |
|---|---|---|
| What it measures | growth of five microorganisms in a preserved liquid | chemical change in a specific molecule |
| What it depends on | the preservative system and the container | the sequence, pH, temperature, oxygen, light, concentration |
| Applies to | preserved, aqueous, multi-entry sterile preparations | any dissolved peptide, preserved or not |
| Source of the number | USP <51> test duration | measured degradation for that peptide under stated conditions |
| Same for every product | yes | no |
A research vial of lyophilized peptide contains no preservative and is not a compounded sterile preparation, so the rule that generates the 28-day number does not even apply to it. The rule does not describe a research solid at all, and it never measured the chemistry of any active ingredient. Anyone quoting 28 days as a peptide fact has borrowed a pharmacy convention and relabelled it.
The site publishes no figure for any material in solution, for that reason. The certificate's valid-until date applies to the dry material, as What minus twenty is actually for explains.
What manufacturers actually say about peptides in solution
The technical guides of peptide manufacturers are the closest thing to published guidance on this question, and none of them gives a number of days for a dissolved peptide.
Bachem's handling and storage guideline is blunt:
Peptides should not be stored in solution (even sterile and oxygen-free solution) because they may slowly undergo chemical degradation.Bachem, Handling and Storage Guidelines for Peptides
It adds that "the long-term storage of peptide solutions is not recommended, especially when the peptide contains Asn, Gln, Cys, Met, or Trp residues." The same document says lyophilized peptides with those residues "have limited shelf lives" even as solids.
LifeTein's guide makes the same point: the dry solid is the storage form.
The manufacturers write in terms of residues, temperatures and mechanisms, because those are what determine the answer. None of the guidance gives a duration, because the answer depends on sequence, pH and temperature.
What happens to a peptide in solution, and why it is sequence-specific
A 2023 review in Pharmaceutics on the stability of therapeutic peptides in aqueous solution lists the chemical routes: "Oxidation, hydrolysis, β-elimination, deamidation, racemization, isomerization, and disulfide exchange," alongside physical routes such as aggregation and adsorption. Each is tied to particular residues and to pH, which is why two peptides in the same solvent at the same temperature can have entirely different lifetimes. Which residues are the fragile ones, and what freezing and thawing does to them, is the subject of Freeze-thaw, aliquots and the residues that oxidize.
The catalog shows the spread. Semax (MEHFPGP) starts with a methionine. MOTS-c (MRWQEMGYIFYPRKLR) has two methionines and a tryptophan. Epitalon (AEDG) is four residues with two acidic side chains and no sulfur. A single number could not describe all of them.
What a formulated product does differently
A factory-made aqueous formulation is engineered around exactly this problem: a buffer to hold the pH near the peptide's most stable point, a preservative that has passed <51>, and a shelf life set by the manufacturer's own stability study of that formulation. The 28-day convention belongs to that world of preserved multi-entry preparations. The comparison of formats is in Vial, spray or strip. A lyophilized research vial has none of those components, which is the reason it ships as a dry solid, a point taken up in Heat and transit.
Sources
- Revisions to USP Compounding Standards <795> and <797>, Brian Serumaga, USP, presentation hosted by NCPA, 2022
- USP General Chapter <51> Antimicrobial Effectiveness Testing, USP 32–NF 27 text as mirrored, accessed 2026-09-21
- Handling and Storage Guidelines for Peptides, Bachem, accessed 2026-09-21
- Handling and Storage of Synthetic Peptides, LifeTein, accessed 2026-09-21
- Nugrahadi PP et al., Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review, Pharmaceutics 15(3):935, 2023
For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.